Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $149000.0.

  • Neurogene's Other Non Operating Income rose 419.58% to $149000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 9015.19%. This contributed to the annual value of $574000.0 for FY2024, which is 9649.04% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Other Non Operating Income is $149000.0, which was up 419.58% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Other Non Operating Income registered a high of $16.4 million during Q4 2023, and its lowest value of $143000.0 during Q1 2024.
  • Its 3-year average for Other Non Operating Income is $2.3 million, with a median of $146000.0 in 2024.
  • Per our database at Business Quant, Neurogene's Other Non Operating Income plummeted by 9911.95% in 2024 and then skyrocketed by 74166.67% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Other Non Operating Income stood at $16.4 million in 2023, then tumbled by 99.12% to $144000.0 in 2024, then rose by 3.47% to $149000.0 in 2025.
  • Its Other Non Operating Income was $149000.0 in Q3 2025, compared to $1.2 million in Q2 2025 and $148000.0 in Q1 2025.